Adherence to 6-month FDC Budesonide/Formoterol treatment and Quality of Life in Greek asthmatic patients-COMPLETE study

N. Rovina (Attica, Greece), D. Simantiraki (Attica, Greece), N. Grekas (Attica, Greece), A. Papataxiarchou (Attica, Greece), A. Athanassiou (Attica, Greece), A. Ginis (Attica, Greece)

Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Session: Inhaled corticosteroids and bronchodilator studies in asthma
Session type: E-poster session
Number: 2639
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Rovina (Attica, Greece), D. Simantiraki (Attica, Greece), N. Grekas (Attica, Greece), A. Papataxiarchou (Attica, Greece), A. Athanassiou (Attica, Greece), A. Ginis (Attica, Greece). Adherence to 6-month FDC Budesonide/Formoterol treatment and Quality of Life in Greek asthmatic patients-COMPLETE study. 2639

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Source: International Congress 2016 – Asthma management
Year: 2016


Quality of life and asthma control in elderly asthmatics: A seven year follow-up – Results from the PRAXIS study
Source: International Congress 2016 – Asthma management in primary care
Year: 2016

Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015

Asthma control in asthmatics treated with extrafine or non-extrafine ICS/LABA combinations in real life setting
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Quality of life and symptoms improvement after 6 months treatment with roflumilast 500 μg daily in a large Greek COPD cohort
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013

Primary care physician assessment of COPD severity: European Health-related Quality of Life in COPD study
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010


Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Comparison of demographic data of patients with COPD treated in primary care by country in European Health-related Quality of Life in COPD study
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010


Adherence to inhaled corticosteroids in asthmatic children in Dutch primary care
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL)
Source: Eur Respir J 2001; 17: 52-58
Year: 2001



X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013

Development of the Satisfaction with Inhaled Asthma Treatment Questionnaire
Source: Eur Respir J 2003; 22: 127-134
Year: 2003



Validation of the Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ) in young Argentinean children
Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure
Year: 2018


Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Adherence to FDC Budesonide/Formoterol treatment and lung function of Greek asthmatic patients–COMPLETE study
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014

Correlating patient characteristics and adherence to their severe asthma inhaler regimen, and assessment of the Medication Adherence Report Scale
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014